News

Press releases and news from regional sources, click on original post link to read the full article and see what’s trending. Click Here to Publish/Feature Your Company or Product News with Biotech Networks

News

RationAle Brewing™ Partners with the Andy Irons Foundation to Launch “Check In Before You Drop In” Campaign for Mental Health Awareness Month

May 1, 2026 SDBN Comments Off on RationAle Brewing™ Partners with the Andy Irons Foundation to Launch “Check In Before You Drop In” Campaign for Mental Health Awareness Month

The non-alcoholic craft beer brand deepens its focus on supporting mental health awareness with a founder-led partnership rooted in surf culture, legacy, and real community impact SAN DIEGO, April 30, 2026 /PRNewswire-PRWeb/ — RationAle Brewing™ […]

No Picture
News

Acadia Pharmaceuticals Announces Planned Year-End Retirement of Elizabeth H.Z. Thompson, Ph.D., Head of Research and Development, Following a Distinguished Career

April 30, 2026 SDBN Comments Off on Acadia Pharmaceuticals Announces Planned Year-End Retirement of Elizabeth H.Z. Thompson, Ph.D., Head of Research and Development, Following a Distinguished Career

SAN DIEGO–(BUSINESS WIRE)–Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced the planned retirement of Elizabeth H.Z. Thompson, Ph.D., Head of Research and Development. Dr. Thompson has decided to retire for personal reasons and informed Acadia of […]


ADVERTISEMENT — Advertise With Biotech Networks

ADVERTISEMENT — Advertise With Biotech Networks

ADVERTISEMENT — Advertise With Biotech Networks
News

Brenig Therapeutics to Present Hybrid AI Drug Discovery Platform at Keystone Symposia Computational Advances in Drug Discovery

April 30, 2026 SDBN Comments Off on Brenig Therapeutics to Present Hybrid AI Drug Discovery Platform at Keystone Symposia Computational Advances in Drug Discovery

BOSTON and SAN DIEGO, April 30, 2026 /PRNewswire/ — Brenig Therapeutics Inc. (Brenig), a clinical-stage biotechnology company advancing best-in-class therapies for neurodegenerative, neuroinflammatory, and cardiometabolic diseases, today announced that Alexei Pushechnikov, PhD, will… Click here […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Calidi Biotherapeutics Announces Strategic Partnership with TransferAI to Drive Efficiencies in the IND Submission Process for CLD-401 Using Agentic AI

April 29, 2026 SDBN Comments Off on Calidi Biotherapeutics Announces Strategic Partnership with TransferAI to Drive Efficiencies in the IND Submission Process for CLD-401 Using Agentic AI

SAN DIEGO, April 29, 2026 (GLOBE NEWSWIRE) — Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi” or the “Company”), a biotechnology company pioneering the development of targeted genetic medicines, announced today that it has entered into […]

No Picture
News

ClearNote Health to Present Industry-Leading Early Detection Data for Avantect® Pancreatic Cancer Test at Digestive Disease Week 2026

April 29, 2026 SDBN Comments Off on ClearNote Health to Present Industry-Leading Early Detection Data for Avantect® Pancreatic Cancer Test at Digestive Disease Week 2026

SAN DIEGO–(BUSINESS WIRE)– #5hmC–ClearNote Health announced its presentation lineup for the upcoming Digestive Disease Week® 2026 conference Click here to view original post Click Here to Publish/Feature Your Company or Product News with Biotech Networks


ADVERTISEMENT — Advertise With Biotech Networks
News

Singular Genomics Names John Stark as Chief Executive Officer as Company Builds on Spatial Platform Momentum

April 28, 2026 SDBN Comments Off on Singular Genomics Names John Stark as Chief Executive Officer as Company Builds on Spatial Platform Momentum

SAN DIEGO, April 28, 2026 /PRNewswire/ — Singular Genomics Systems, Inc. today announced the appointment of John Stark as Chief Executive Officer. This leadership transition comes as Singular builds on the launch of its market-leading […]

No Picture
News

Genexine’s First-in-Class SOX2 Degrader GX-BP1 Demonstrates Up to 96% TGI and Eliminates Tumor Regrowth in Preclinical Models

April 28, 2026 SDBN Comments Off on Genexine’s First-in-Class SOX2 Degrader GX-BP1 Demonstrates Up to 96% TGI and Eliminates Tumor Regrowth in Preclinical Models

SEOUL, South Korea–(BUSINESS WIRE)– #GENEXINE–Genexine, Inc. (KOSDAQ: 095700), a clinical-stage biotechnology company, today announced new preclinical data for its SOX2-targeting bioPROTAC candidate, GX-BP1, presented at the American Association for Cancer Research (AACR) Annual Meeting 2026 […]

News

FuturHealth Among the First to Offer Eli Lilly’s Oral GLP-1, Orforglipron, Expanding Access to Next-Generation, Non-Injectable Treatment

April 28, 2026 SDBN Comments Off on FuturHealth Among the First to Offer Eli Lilly’s Oral GLP-1, Orforglipron, Expanding Access to Next-Generation, Non-Injectable Treatment

The once-daily pill is now available through FuturHealth with home delivery SAN DIEGO, April 28, 2026 /PRNewswire/ — FuturHealth, a clinically-guided health platform designed to support long-term health beyond weight loss, today announced that it […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Innovive Expands Global Reach Through Strategic Partnership with Attentive Science to Accelerate Scientific Research Across GCC and MENA Regions

April 28, 2026 SDBN Comments Off on Innovive Expands Global Reach Through Strategic Partnership with Attentive Science to Accelerate Scientific Research Across GCC and MENA Regions

SAN DIEGO–(BUSINESS WIRE)– #Biotech–Innovive Expands Global Reach Through Strategic Partnership with Attentive Science to Accelerate Scientific Research Across GCC and MENA Regions Click here to view original post Click Here to Publish/Feature Your Company or […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Sapient Launches Tumor Protein Mapping Platform to Characterize Functional Biology Across Critical Dimensions in Human Tumors

April 28, 2026 SDBN Comments Off on Sapient Launches Tumor Protein Mapping Platform to Characterize Functional Biology Across Critical Dimensions in Human Tumors

SAN DIEGO–(BUSINESS WIRE)– #biomarkers–Sapient, a leader in multi-omics data generation for biomarker discovery and clinical insight delivery, has announced the launch of its Tumor Protein Mapping Platform as a suite of mass spectrometry-based discovery proteomics […]

News

Graybill Medical Group Cuts Front-Office Costs by 50% and Improves Patient Access Through AI-Driven Transformation

April 28, 2026 SDBN Comments Off on Graybill Medical Group Cuts Front-Office Costs by 50% and Improves Patient Access Through AI-Driven Transformation

LOS ANGELES, April 28, 2026 /PRNewswire/ — Third Way Health, Inc. (TWH), a leading AI-enabled services partner for healthcare organizations, today announced measurable operational and patient experience gains from its partnership with Graybill Medical Group, […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Ionis partner GSK announces bepirovirsen accepted for Priority Review and granted Breakthrough Therapy Designation by U.S. FDA as a potential first-in-class medicine for chronic hepatitis B

April 27, 2026 SDBN Comments Off on Ionis partner GSK announces bepirovirsen accepted for Priority Review and granted Breakthrough Therapy Designation by U.S. FDA as a potential first-in-class medicine for chronic hepatitis B

CARLSBAD, Calif.–(BUSINESS WIRE)–Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) partner GSK today announced the U.S. Food and Drug Administration (FDA) has accepted for Priority Review the New Drug Application (NDA) for bepirovirsen, an investigational antisense oligonucleotide (ASO) […]

No Picture
News

New Peer?Reviewed Study Reveals Actionable Immune–Microenvironment Target in Brain Metastasis; Medicinova Advances Clinical Translation

April 27, 2026 SDBN Comments Off on New Peer?Reviewed Study Reveals Actionable Immune–Microenvironment Target in Brain Metastasis; Medicinova Advances Clinical Translation

LA JOLLA, Calif., April 27, 2026 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), today […]


ADVERTISEMENT — Advertise With Biotech Networks
News

The Engineer Who Taught Cells to Behave

April 27, 2026 SDBN Comments Off on The Engineer Who Taught Cells to Behave

Bernhard Palsson builds computer models that help scientists make biology easier to predict — and easier to engineer. His work has influenced everything from microbe-made chemicals to cells used to produce therapeutic proteins and efforts […]

No Picture
News

Cardiff Oncology to Host Key Opinion Leader Discussion on Onvansertib’s Promising Single-Agent Activity

April 27, 2026 SDBN Comments Off on Cardiff Oncology to Host Key Opinion Leader Discussion on Onvansertib’s Promising Single-Agent Activity

SAN DIEGO, April 27, 2026 (GLOBE NEWSWIRE) — Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, today announced that the Company will […]